jCyte Launches New Phase 2 Clinical Trial for its Cell-Based RP Therapy
Foundation Fighting Blindness

jCyte Launches New Phase 2 Clinical Trial for its Cell-Based RP Therapy

2025-08-20
The trial is evaluating a cell dose that is 50 percent higher than the highest dose used in a previous Phase 2b trial.
Comments (3)

More Episodes

All Episodes>>

Get this podcast on your phone, Free

Create Your Podcast In Minutes

  • Full-featured podcast site
  • Unlimited storage and bandwidth
  • Comprehensive podcast stats
  • Distribute to Apple Podcasts, Spotify, and more
  • Make money with your podcast
Get Started
It is Free